Skip to main content
OpenTrials
Completed

NCT Number: NCT04797663

Long-pulsed 1064 nm Nd-YAG Laser Versus TCA 20% in Treatment of Keratosis Pilaris

Keratosis pilaris (KP) is a common disorder of keratinization. There are different treatment modalities for KP with variable results. Nd:YAG laser and chemical peels are among these treatment modalities, however, there is no enough evidence in the literature regarding their efficacy. The aim of this study is to assess and compare the efficacy of long pulsed Nd:YAG laser and trichloreacetic acid 20% in treatment of keratosis pilaris.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Kasr Alainy

Cairo, 11562, Egypt

About this study

Keratosis pilaris (KP) is a genetic disorder of keratinization of hair follicles of skin. It's a very common benign condition that manifests as small, rough folliculocentric keratotic papules, often described as chicken bumps, chicken skin or goose-bumps, in characteristic areas of body, particularly the outer upper arms and thighs.

Trichloreacetic acid (TCA) is a type of chemical peels that is derived from acetic acid by the chlorination of 3 hydrogen ions. It can induce coagulative necrosis of proteins and cells. The depth of action depends on various factors e.g the number of layers applied and its combination with substances that potentiate its action.

Nd: YAG laser is a type of hair removing devices that operates at wave length of 1064nm. This wave length allows for less absorption at the epidermis. It is less absorbed by melanin, which leads to lower side effect and better tolerance but less efficacy in dark skinned patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients above 18 years with KP.
  • Patients with KP affecting back of the trunk, arms, thighs, forearms, legs and buttocks.

Exclusion criteria

  • Pregnant or lactating females.
  • Patients who had performed any laser treatment for KP within 6 months prior to the study.
  • Patients with history of oral retinoids within 3 months prior to the study.
  • Patients with history of hypertrophic scars or keloids.
  • Patients who used any topical treatment one month prior to the session.
  • Patients with acne affecting the same sites of keratosis pilaris.
  • Patients with active skin diseases affecting the area involved with KP e.g. folliculitis and eczema.

Treatment and study plan

Nd-YAG laser

Device

laser hair removal device

Other names: 1064 nm laser

TCA 20%

Drug

chemical peel

Other names: Trichloroacetic acid

Primary outcomes

  1. Change of clinical and dermoscopic scores of KP with Nd-YAG laser

    Time frame: 4 months

    the change in roughness and color of KP by clinical score after 4 sessions of Nd-YAG laser. the score ranges from 0-4. where 0 is no change and 4 is excellent improvement

  2. Change of clinical and dermoscopic scores of KP with TCA 20%

    Time frame: 4 months

    the change in roughness and color of KP by clinical score after 4 sessions of TCA 20% peel. the score ranges from 0-4. where 0 is no change and 4 is excellent improvement

Secondary outcomes

  1. safety and tolerability of Nd-YAG laser and TCA 20% in treatment of KP: adverse events

    Time frame: 4 months

    adverse effects of treatment modalities, if any

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Clinical and Dermoscopic Evaluation of Long-pulsed 1064 nm Nd-YAG Laser Versus Trichloroacetic Acid 20% in Treatment of Keratosis Pilaris

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Mar 15, 2021
Registry last updated
Aug 3, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.